|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased activity of AKT1 protein]]; Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased activity of AKT1 protein] |
CTD |
PMID:26048653 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Ecdysterone results in increased expression of BAX protein |
CTD |
PMID:33878320 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression |
ISO |
Ecdysterone affects the expression of BCL2 protein |
CTD |
PMID:33878320 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases activity increases cleavage |
ISO |
Ecdysterone results in increased activity of CASP3 protein Ecdysterone results in increased cleavage of CASP3 protein |
CTD |
PMID:29126784 PMID:33878320 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein]]; Ecdysterone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of and results in decreased activity of GSK3B protein] |
CTD |
PMID:26048653 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 protein]]; Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 mRNA]; Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 protein] |
CTD |
PMID:26048653 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression increases expression |
ISO |
Ecdysterone results in decreased expression of HSPA5 protein Ecdysterone results in increased expression of HSPA5 mRNA |
CTD |
PMID:29126784 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
affects expression |
ISO |
Ecdysterone affects the expression of MTOR protein |
CTD |
PMID:33878320 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases response to substance |
EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein]]; Ecdysterone promotes the reaction [1-Methyl-4-phenylpyridinium affects the localization of NFE2L2 protein] NFE2L2 results in increased susceptibility to Ecdysterone |
CTD |
PMID:26048653 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Ecdysterone results in increased cleavage of PARP1 protein |
CTD |
PMID:33878320 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Sqstm1 |
sequestosome 1 |
affects expression |
ISO |
Ecdysterone affects the expression of SQSTM1 protein |
CTD |
PMID:33878320 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
bufalin inhibits the reaction [ABCB1 protein results in increased transport of quinidinium] |
CTD |
PMID:23104431 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
bufalin results in increased expression of ACTB protein |
CTD |
PMID:23091618 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
ISO |
bufalin results in increased expression of ACTG1 protein |
CTD |
PMID:23091618 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
bufalin results in increased phosphorylation of and results in decreased expression of AKT1 protein bufalin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:23949904 PMID:36924737 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
bufalin results in increased expression of APAF1 protein |
CTD |
PMID:27444971 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
bufalin results in decreased expression of BCL2 mRNA; bufalin results in decreased expression of BCL2 protein |
CTD |
PMID:7658701 PMID:27444971 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
bufalin results in increased expression of BCL2L11 protein |
CTD |
PMID:36924737 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Casp3 |
caspase 3 |
increases expression increases activity |
ISO |
bufalin results in increased expression of CASP3 mRNA; bufalin results in increased expression of CASP3 protein modified form bufalin results in increased activity of CASP3 protein |
CTD |
PMID:27444971 PMID:36924737 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
bufalin results in increased activity of CASP9 protein |
CTD |
PMID:27444971 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cope |
COPI coat complex subunit epsilon |
decreases expression |
ISO |
bufalin results in decreased expression of COPE protein |
CTD |
PMID:23091618 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions increases expression |
ISO |
bufalin inhibits the reaction [HSPB1 protein binds to CYCS protein]; HSPB1 protein inhibits the reaction [bufalin inhibits the reaction [HSPB1 protein binds to CYCS protein]] bufalin results in increased expression of CYCS protein |
CTD |
PMID:23091618 PMID:27444971 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing multiple interactions increases expression |
ISO |
CYP3A4 protein results in increased metabolism of bufalin bufalin promotes the reaction [CYP3A4 protein results in increased metabolism of Midazolam]; bufalin results in increased expression of and results in increased activity of CYP3A4 protein; Ketoconazole inhibits the reaction [CYP3A4 protein results in increased metabolism of bufalin] bufalin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:22178124 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
bufalin results in increased expression of DDIT3 mRNA |
CTD |
PMID:27444971 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dnajb11 |
DnaJ heat shock protein family (Hsp40) member B11 |
increases expression |
ISO |
bufalin results in increased expression of DNAJB11 protein |
CTD |
PMID:23091618 |
|
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
bufalin results in decreased expression of DUT protein |
CTD |
PMID:23091618 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
decreases phosphorylation |
ISO |
bufalin results in decreased phosphorylation of EIF2AK3 protein |
CTD |
PMID:23949904 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
bufalin results in increased expression of ENDOG mRNA; bufalin results in increased expression of ENDOG protein |
CTD |
PMID:27444971 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno1 |
enolase 1 |
decreases expression |
ISO |
bufalin results in decreased expression of ENO1 protein |
CTD |
PMID:23091618 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
bufalin results in increased expression of FAS protein |
CTD |
PMID:27444971 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
bufalin results in increased expression of FASLG protein |
CTD |
PMID:27444971 PMID:36924737 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased expression of FOS mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bufalin results in increased expression of FOS mRNA] |
CTD |
PMID:10712238 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
bufalin results in increased expression of and results in decreased phosphorylation of FOXO1 protein |
CTD |
PMID:36924737 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
decreases expression |
ISO |
bufalin results in decreased expression of GRB2 protein |
CTD |
PMID:23949904 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases expression |
ISO |
bufalin results in decreased expression of GSTP1 protein |
CTD |
PMID:23091618 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
decreases expression |
ISO |
bufalin results in decreased expression of HNRNPH1 protein |
CTD |
PMID:23091618 |
|
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
|
|
G |
Hnrnpk |
heterogeneous nuclear ribonucleoprotein K |
decreases expression |
ISO |
bufalin results in decreased expression of HNRNPK protein |
CTD |
PMID:23091618 |
|
NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
decreases expression |
ISO |
bufalin results in decreased expression of HSPA5 mRNA |
CTD |
PMID:27444971 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
multiple interactions decreases response to substance decreases expression |
ISO |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [bufalin results in decreased expression of HSPB1 protein]; bufalin inhibits the reaction [HSPB1 protein binds to CYCS protein]; HSPB1 protein inhibits the reaction [bufalin affects the localization of RELA protein]; HSPB1 protein inhibits the reaction [bufalin inhibits the reaction [HSPB1 protein binds to CYCS protein]]; HSPB1 protein inhibits the reaction [bufalin results in increased cleavage of PARP1 protein] HSPB1 protein results in decreased susceptibility to bufalin |
CTD |
PMID:23091618 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased expression of IL1B mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bufalin results in increased expression of IL1B mRNA]; Ro 31-8220 inhibits the reaction [bufalin results in increased expression of IL1B mRNA]; SB 203580 promotes the reaction [bufalin results in increased expression of IL1B mRNA] |
CTD |
PMID:10712238 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases phosphorylation |
ISO |
bufalin results in decreased phosphorylation of JUN protein |
CTD |
PMID:23949904 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Krt18 |
keratin 18 |
increases expression |
ISO |
bufalin results in increased expression of KRT18 protein |
CTD |
PMID:23091618 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
decreases expression |
ISO |
bufalin results in decreased expression of MAP2K7 protein |
CTD |
PMID:23949904 |
|
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
decreases expression |
ISO |
bufalin results in decreased expression of MAP3K3 protein |
CTD |
PMID:23949904 |
|
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation decreases activity increases phosphorylation |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein]; Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK1 protein]; SB 203580 promotes the reaction [bufalin results in increased phosphorylation of MAPK1 protein] bufalin results in decreased phosphorylation of MAPK1 protein bufalin results in decreased activity of MAPK1 protein |
CTD |
PMID:10712238 PMID:21922632 PMID:36924737 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation decreases activity increases phosphorylation |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [bufalin results in increased phosphorylation of MAPK3 protein]; Ro 31-8220 inhibits the reaction [bufalin results in increased phosphorylation of MAPK3 protein]; SB 203580 promotes the reaction [bufalin results in increased phosphorylation of MAPK3 protein] bufalin results in decreased phosphorylation of MAPK3 protein bufalin results in decreased activity of MAPK3 protein |
CTD |
PMID:10712238 PMID:21922632 PMID:36924737 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases activity |
ISO |
bufalin results in decreased activity of MAPK8 protein |
CTD |
PMID:21922632 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases activity |
ISO |
bufalin results in decreased activity of MAPK9 protein |
CTD |
PMID:21922632 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
ISO |
bufalin co-treated with osimertinib decreases expression of MCL1 protein in lung Bufalin decreases expression of MCL1 protein in lung |
RGD |
PMID:31301315 PMID:28419994 |
RGD:151356917, RGD:151356918 |
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
bufalin results in decreased expression of MKI67 protein |
CTD |
PMID:36924737 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases expression |
ISO |
bufalin results in decreased expression of MMP1 protein |
CTD |
PMID:23949904 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases secretion decreases expression |
ISO |
bufalin results in decreased expression of and results in decreased activity of MMP2 protein bufalin results in decreased secretion of MMP2 protein bufalin results in decreased expression of MMP2 mRNA |
CTD |
PMID:21922632 PMID:23949904 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity decreases secretion multiple interactions decreases expression |
ISO |
bufalin results in decreased activity of MMP9 protein bufalin results in decreased secretion of MMP9 protein bufalin results in decreased expression of and results in decreased activity of MMP9 protein bufalin results in decreased expression of MMP9 mRNA |
CTD |
PMID:21922632 PMID:23949904 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
bufalin results in decreased expression of MYC mRNA |
CTD |
PMID:7658701 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
bufalin results in decreased expression of NOS2 protein |
CTD |
PMID:23949904 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
bufalin results in increased cleavage of PARP1 protein HSPB1 protein inhibits the reaction [bufalin results in increased cleavage of PARP1 protein] |
CTD |
PMID:23091618 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
decreases expression |
ISO |
bufalin results in decreased expression of PPA1 protein |
CTD |
PMID:23091618 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Ppp2cb |
protein phosphatase 2 catalytic subunit beta |
decreases expression |
ISO |
bufalin results in decreased expression of PPP2CB protein |
CTD |
PMID:23091618 |
|
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
|
|
G |
Psma3 |
proteasome 20S subunit alpha 3 |
decreases expression |
ISO |
bufalin results in decreased expression of PSMA3 protein |
CTD |
PMID:23091618 |
|
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
bufalin results in decreased expression of PTGS2 protein |
CTD |
PMID:23949904 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases expression |
ISO |
bufalin results in decreased expression of PTK2 protein |
CTD |
PMID:23949904 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases expression multiple interactions affects localization |
ISO |
bufalin results in decreased expression of RELA protein HSPB1 protein inhibits the reaction [bufalin affects the localization of RELA protein] |
CTD |
PMID:23091618 PMID:23949904 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
bufalin results in decreased expression of RHOA protein |
CTD |
PMID:23949904 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
decreases expression |
ISO |
bufalin results in decreased expression of ROCK1 protein |
CTD |
PMID:23949904 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rplp0 |
ribosomal protein lateral stalk subunit P0 |
decreases expression |
ISO |
bufalin results in decreased expression of RPLP0 protein |
CTD |
PMID:23091618 |
|
NCBI chr12:41,054,363...41,057,632
Ensembl chr12:41,054,179...41,057,632
|
|
G |
Rpsa |
ribosomal protein SA |
increases expression |
ISO |
bufalin results in increased expression of RPSA protein |
CTD |
PMID:23091618 |
|
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
increases expression |
ISO |
bufalin results in increased expression of SARNP protein |
CTD |
PMID:23091618 |
|
NCBI chr 7:1,251,096...1,305,335
Ensembl chr 7:1,251,098...1,305,332
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
bufalin results in decreased expression of SOS1 protein |
CTD |
PMID:23949904 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Tardbp |
TAR DNA binding protein |
decreases expression |
ISO |
bufalin results in decreased expression of TARDBP protein |
CTD |
PMID:23091618 |
|
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tcp1 |
t-complex 1 |
decreases expression |
ISO |
bufalin results in decreased expression of TCP1 protein |
CTD |
PMID:23091618 |
|
NCBI chr 1:47,829,061...47,836,809
Ensembl chr 1:47,828,652...47,836,839
|
|
G |
Tmod3 |
tropomodulin 3 |
decreases expression |
ISO |
bufalin results in decreased expression of TMOD3 protein |
CTD |
PMID:23091618 |
|
NCBI chr 8:76,248,978...76,310,855
Ensembl chr 8:76,248,979...76,310,977
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
ISO |
bufalin results in increased expression of TNF mRNA SB 203580 promotes the reaction [bufalin results in increased expression of TNF mRNA] |
CTD |
PMID:10712238 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
decreases expression |
ISO |
bufalin results in decreased expression of TPI1 protein |
CTD |
PMID:23091618 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
ISO |
bufalin results in decreased expression of TPT1 protein |
CTD |
PMID:23091618 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
bufalin results in decreased expression of VEGFA protein |
CTD |
PMID:23949904 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Digitoxigenin results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Digitoxigenin results in decreased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases expression |
ISO |
Digitoxigenin results in decreased expression of CCL5 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Digitoxigenin results in decreased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Digitoxigenin results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases transport |
ISO |
Digitoxin inhibits the reaction [ABCB1 protein results in increased transport of quinidinium] ABCB1 protein results in increased transport of Digitoxin |
CTD |
PMID:23104431 PMID:26708294 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of AR protein |
CTD |
PMID:25752796 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of BIRC5 protein; Digitoxin results in decreased expression of BIRC5 protein |
CTD |
PMID:22037315 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
decreases expression multiple interactions |
ISO |
Digitoxin analog results in decreased expression of CASP3 protein; Digitoxin results in decreased expression of CASP3 protein Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]; Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]] |
CTD |
PMID:22037315 PMID:34717917 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases cleavage multiple interactions |
ISO |
Digitoxin analog results in increased cleavage of CASP8 protein; Digitoxin results in increased cleavage of CASP8 protein Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]; Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]] |
CTD |
PMID:22037315 PMID:34717917 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
Digitoxin analog results in increased cleavage of CASP9 protein; Digitoxin results in increased cleavage of CASP9 protein |
CTD |
PMID:22037315 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]]; Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] |
CTD |
PMID:19446813 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions decreases expression |
ISO |
Digitoxin analog results in decreased expression of [CCNB1 protein binds to CDK1 protein]; Digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein] Digitoxin analog results in decreased expression of CCNB1 protein; Digitoxin results in decreased expression of CCNB1 protein |
CTD |
PMID:22037315 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
Digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]; Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]; HIF1A protein affects the reaction [Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]]; STAT3 protein affects the reaction [Digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]] Digitoxin results in decreased expression of CCND1 protein |
CTD |
PMID:34717917 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression multiple interactions |
ISO |
Digitoxin analog results in decreased expression of CDK1 protein; Digitoxin results in decreased expression of CDK1 protein Digitoxin analog results in decreased expression of [CCNB1 protein binds to CDK1 protein]; Digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein] |
CTD |
PMID:22037315 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of CDKN1A protein; Digitoxin results in decreased expression of CDKN1A protein |
CTD |
PMID:22037315 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of CDKN1B protein; Digitoxin results in decreased expression of CDKN1B protein |
CTD |
PMID:22037315 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Chek1 |
checkpoint kinase 1 |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of CHEK1 protein; Digitoxin results in decreased expression of CHEK1 protein |
CTD |
PMID:22037315 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of CHEK2 protein; Digitoxin results in decreased expression of CHEK2 protein |
CTD |
PMID:22037315 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
Digitoxin analog results in increased expression of CYCS protein; Digitoxin results in increased expression of CYCS protein |
CTD |
PMID:22037315 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions decreases phosphorylation |
ISO |
Digitoxin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of EIF4EBP1 protein] Digitoxin results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:34717917 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:25752796 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of ESR2 protein |
CTD |
PMID:25752796 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fancd2 |
FA complementation group D2 |
multiple interactions |
ISO |
Digitoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein] |
CTD |
PMID:24124520 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fanci |
FA complementation group I |
multiple interactions |
ISO |
Digitoxin inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] |
CTD |
PMID:24124520 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]; Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]; Digitoxin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Oxygen deficiency results in increased expression of HIF1A protein]]; Digitoxin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein]; Digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]]; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]]; HIF1A protein affects the reaction [Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]]; STAT3 protein affects the reaction [Digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]] |
CTD |
PMID:34717917 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]]; Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK1 protein]; Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK3 protein]; Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]; Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]; Digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein] |
CTD |
PMID:19446813 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK1 protein] |
CTD |
PMID:19446813 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK3 protein] |
CTD |
PMID:19446813 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]]; Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] |
CTD |
PMID:19446813 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
decreases phosphorylation |
ISO |
Digitoxin results in decreased phosphorylation of NFKBIA protein |
CTD |
PMID:15136726 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions increases activity |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin results in increased activity of NOS3 protein]; Calcium deficiency inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] |
CTD |
PMID:19446813 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of PGR protein |
CTD |
PMID:25752796 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pias3 |
protein inhibitor of activated STAT, 3 |
increases expression |
ISO |
Digitoxin results in increased expression of PIAS3 protein |
CTD |
PMID:34717917 |
|
NCBI chr 2:184,232,546...184,241,455
Ensembl chr 2:184,232,571...184,241,480
|
|
G |
Pten |
phosphatase and tensin homolog |
increases expression |
ISO |
Digitoxin results in increased expression of PTEN protein |
CTD |
PMID:34717917 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
increases expression |
ISO |
Digitoxin results in increased expression of PTPN6 protein |
CTD |
PMID:34717917 |
|
NCBI chr 4:157,526,034...157,550,783
Ensembl chr 4:157,526,035...157,550,984
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases phosphorylation multiple interactions |
ISO |
Digitoxin results in decreased phosphorylation of RPS6KB1 protein [Digitoxin co-treated with Oxygen deficiency] results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:34717917 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Digitoxin co-treated with Oxygen deficiency] results in decreased expression of and results in decreased phosphorylation of STAT3 protein; Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]; Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]; Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]; Digitoxin results in decreased expression of and results in decreased phosphorylation of STAT3 protein; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP3 protein]]; HIF1A protein affects the reaction [Digitoxin affects the reaction [STAT3 protein affects the cleavage of CASP8 protein]]; HIF1A protein affects the reaction [Digitoxin promotes the reaction [STAT3 protein affects the expression of CCND1 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP3 protein]]; STAT3 protein affects the reaction [Digitoxin affects the reaction [HIF1A protein affects the cleavage of CASP8 protein]]; STAT3 protein affects the reaction [Digitoxin promotes the reaction [HIF1A protein affects the expression of CCND1 protein]] |
CTD |
PMID:34717917 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of THRA protein |
CTD |
PMID:25752796 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
Digitoxin binds to and results in decreased activity of THRB protein |
CTD |
PMID:25752796 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression |
ISO |
Digitoxin analog results in decreased expression of TP53 protein; Digitoxin results in decreased expression of TP53 protein |
CTD |
PMID:22037315 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
Digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein] |
CTD |
PMID:19446813 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases transport |
ISO |
ABCB1 protein results in increased transport of Digoxigenin |
CTD |
PMID:26708294 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Digoxigenin results in decreased expression of CCL2 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
decreases expression |
ISO |
Digoxigenin results in decreased expression of CCL4 protein |
CTD |
PMID:20116850 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions increases expression |
ISO |
Digoxigenin promotes the reaction [RORC protein binds to G6PC1 promoter] Digoxigenin results in increased expression of G6PC1 mRNA |
CTD |
PMID:29981919 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Digoxigenin results in increased expression of and results in increased secretion of IL17A protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17f |
interleukin 17F |
multiple interactions |
ISO |
Digoxigenin results in increased expression of and results in increased secretion of IL17F protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
Digoxigenin results in decreased expression of IL6R protein modified form |
CTD |
PMID:20116850 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression multiple interactions |
ISO |
Digoxigenin results in increased expression of NPAS2 mRNA Digoxigenin promotes the reaction [RORC protein binds to NPAS2 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases expression multiple interactions |
ISO |
Digoxigenin results in increased expression of RORC mRNA Digoxigenin promotes the reaction [RORC protein binds to G6PC1 promoter]; Digoxigenin promotes the reaction [RORC protein binds to NPAS2 promoter]; RORC protein promotes the reaction [Digoxigenin results in increased expression of RORC mRNA] |
CTD |
PMID:29981919 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Digoxigenin results in decreased expression of VEGFA protein |
CTD |
PMID:20116850 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions increases expression |
ISO |
dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter] dihydroouabain results in increased expression of G6PC1 mRNA |
CTD |
PMID:29981919 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
dihydroouabain results in increased expression of and results in increased secretion of IL17A protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17f |
interleukin 17F |
multiple interactions |
ISO |
dihydroouabain results in increased expression of and results in increased secretion of IL17F protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression multiple interactions |
ISO |
dihydroouabain results in increased expression of NPAS2 mRNA dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions increases expression |
ISO |
dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter]; dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter]; RORC protein promotes the reaction [dihydroouabain results in increased expression of RORC mRNA] |
CTD |
PMID:29981919 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
hellebrigenin results in decreased phosphorylation of and results in decreased expression of AKT1 protein |
CTD |
PMID:24954031 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Atm |
ATM serine/threonine kinase |
increases phosphorylation |
ISO |
hellebrigenin results in increased phosphorylation of ATM protein |
CTD |
PMID:24954031 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization |
ISO |
hellebrigenin affects the localization of BAX protein |
CTD |
PMID:24954031 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
hellebrigenin results in increased expression of CCNB1 protein |
CTD |
PMID:24954031 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases phosphorylation |
ISO |
hellebrigenin results in decreased phosphorylation of CDC25C protein |
CTD |
PMID:24954031 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases phosphorylation |
ISO |
hellebrigenin results in increased phosphorylation of CDK1 protein |
CTD |
PMID:24954031 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases phosphorylation |
ISO |
hellebrigenin results in increased phosphorylation of CHEK2 protein |
CTD |
PMID:24954031 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases activity |
ISO |
hellebrigenin results in increased activity of PARP1 protein |
CTD |
PMID:24954031 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
|
G |
Rorc |
RAR-related orphan receptor C |
increases expression |
ISO |
helveticoside results in increased expression of RORC mRNA |
CTD |
PMID:29981919 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
oleandrin results in increased activity of CASP3 protein |
CTD |
PMID:24172227 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
oleandrin results in increased activity of CASP8 protein |
CTD |
PMID:24172227 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
increases expression |
ISO |
oleandrin results in increased expression of CXCR1 mRNA; oleandrin results in increased expression of CXCR1 protein |
CTD |
PMID:24172227 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
increases expression |
ISO |
oleandrin results in increased expression of CXCR2 mRNA; oleandrin results in increased expression of CXCR2 protein |
CTD |
PMID:24172227 |
|
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
oleandrin results in increased expression of CXCR4 mRNA |
CTD |
PMID:24172227 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
|
G |
A2m |
alpha-2-macroglobulin |
affects expression |
ISO |
Ouabain affects the expression of A2M protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; [Ouabain results in increased expression of ABCB1] which results in decreased susceptibility to Doxorubicin; KN 93 inhibits the reaction [Ouabain results in increased expression of ABCB1 protein] Ouabain results in increased expression of ABCB1 mRNA; Ouabain results in increased expression of ABCB1 protein |
CTD |
PMID:19647009 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
affects expression |
ISO |
Ouabain affects the expression of ACAA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Ace |
angiotensin I converting enzyme |
affects expression |
EXP |
Ouabain affects the expression of ACE mRNA; Ouabain affects the expression of ACE protein |
CTD |
PMID:16565308 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
ISO |
Ouabain affects the expression of ACTA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adh1c |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
ISO |
Ouabain affects the expression of ADH1C protein |
CTD |
PMID:17268060 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Agt |
angiotensinogen |
affects expression increases expression |
EXP |
Ouabain affects the expression of AGT protein Ouabain results in increased expression of AGT protein |
CTD |
PMID:11768735 PMID:16565308 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression affects expression |
EXP |
Ouabain results in decreased expression of AGTR1A protein Ouabain affects the expression of AGTR1A mRNA |
CTD |
PMID:16565308 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
Ouabain results in increased expression of AIFM1 protein |
CTD |
PMID:31436044 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Anxa1 |
annexin A1 |
affects expression |
ISO |
Ouabain affects the expression of ANXA1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
affects expression |
ISO |
Ouabain affects the expression of ANXA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
Ouabain results in increased expression of APAF1 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of ARAF mRNA |
CTD |
PMID:16412265 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of ARIH1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245
|
|
G |
Arpc5 |
actin related protein 2/3 complex, subunit 5 |
affects expression |
ISO |
Ouabain affects the expression of ARPC5 protein |
CTD |
PMID:17268060 |
|
NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
|
|
G |
Arrb1 |
arrestin, beta 1 |
increases expression |
ISO |
Ouabain results in increased expression of ARRB1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
affects expression |
ISO |
Ouabain affects the expression of ASAH1 protein |
CTD |
PMID:17268060 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Atf6b |
activating transcription factor 6 beta |
increases expression |
ISO |
Ouabain results in increased expression of ATF6B protein |
CTD |
PMID:31436044 |
|
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
|
|
G |
Atm |
ATM serine/threonine kinase |
increases phosphorylation |
ISO |
Ouabain results in increased phosphorylation of ATM protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
multiple interactions |
ISO |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions increases expression affects expression affects binding |
ISO EXP |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 mRNA]; Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 protein] Ouabain affects the expression of ATP1A1 protein Ouabain results in increased expression of ATP1A1 mRNA; Ouabain results in increased expression of ATP1A1 protein Ouabain binds to ATP1A1 protein |
CTD |
PMID:11768735 PMID:11834625 PMID:12479229 PMID:16716361 PMID:19995221 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
multiple interactions increases expression decreases expression affects expression decreases activity affects response to substance affects binding |
ISO EXP |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] Ouabain results in increased expression of ATP1A2 protein Ouabain results in decreased expression of ATP1A2 mRNA Ouabain affects the expression of ATP1A2 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A2 mRNA] Ouabain results in decreased activity of ATP1A2 protein Ouabain binds to and results in decreased activity of ATP1A2 protein ATP1A2 protein affects the susceptibility to Ouabain Ouabain binds to ATP1A2 protein |
CTD |
PMID:11834625 PMID:12479229 PMID:15458945 PMID:16166162 PMID:16716361 PMID:18487447 PMID:19687166 PMID:19897708 PMID:19995221 More...
|
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
increases expression multiple interactions decreases expression affects expression affects binding |
ISO EXP |
Ouabain results in increased expression of ATP1A3 mRNA; Ouabain results in increased expression of ATP1A3 protein Potassium Chloride inhibits the reaction [ATP1A3 protein binds to Ouabain] Ouabain results in decreased expression of ATP1A3 mRNA Ouabain affects the expression of ATP1A3 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A3 mRNA] ATP1A3 protein binds to Ouabain; Ouabain binds to ATP1A3 protein |
CTD |
PMID:11204457 PMID:12479229 PMID:15276875 PMID:19687166 PMID:19995221 PMID:24631656 More...
|
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions increases expression |
EXP |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; Calcium affects the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; W 7 inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] |
CTD |
PMID:11204457 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp4b |
ATPase H+/K+ transporting subunit beta |
multiple interactions |
ISO |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr16:76,144,150...76,153,063
Ensembl chr16:76,144,150...76,153,063
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
affects expression |
ISO |
Ouabain affects the expression of ATP5F1A protein |
CTD |
PMID:17268060 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases phosphorylation |
ISO |
Ouabain results in decreased phosphorylation of ATR protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Bahd1 |
bromo adjacent homology domain containing 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of BAHD1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization increases expression multiple interactions |
ISO |
Ouabain affects the localization of BAX protein Ouabain results in increased expression of BAX protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein] |
CTD |
PMID:17096883 PMID:18247327 PMID:31436044 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Ouabain results in decreased expression of BCL2 protein |
CTD |
PMID:31436044 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of BCL2L1 protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions decreases expression |
EXP |
Lithium inhibits the reaction [Ouabain results in decreased expression of BDNF protein] |
CTD |
PMID:19954800 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
Ouabain results in decreased expression of BRCA1 protein |
CTD |
PMID:31436044 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CALB1 protein |
CTD |
PMID:20105455 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calml5 |
calmodulin-like 5 |
affects expression |
ISO |
Ouabain affects the expression of CALML5 protein |
CTD |
PMID:17268060 |
|
NCBI chr17:66,394,433...66,395,352
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Ouabain results in increased expression of CAMK2B protein |
CTD |
PMID:31436044 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Canx |
calnexin |
increases expression |
ISO |
Ouabain results in increased expression of CANX protein |
CTD |
PMID:18247327 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity |
ISO EXP |
Ouabain results in increased expression of CASP3 protein Ouabain results in increased activity of and results in increased cleavage of CASP3 protein Ouabain results in increased activity of CASP3 protein |
CTD |
PMID:11435898 PMID:17096883 PMID:18247327 PMID:20435043 PMID:31436044 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
ISO |
Ouabain results in increased expression of CASP4 protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased activity of CASP8 protein |
CTD |
PMID:31436044 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased activity of CASP9 protein |
CTD |
PMID:31436044 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP |
Lithium inhibits the reaction [Ouabain results in decreased activity of CAT protein]; Valproic Acid inhibits the reaction [Ouabain results in decreased activity of CAT protein] |
CTD |
PMID:20627318 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CAV1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccdc14 |
coiled-coil domain containing 14 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCDC14 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr11:66,052,063...66,087,915
Ensembl chr11:66,052,620...66,087,956
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] Ouabain results in increased expression of CCL2 mRNA; Ouabain results in increased expression of CCL2 protein |
CTD |
PMID:11340305 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCNA1 mRNA |
CTD |
PMID:20460749 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCNA2 mRNA |
CTD |
PMID:21215801 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCND1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of CDH1 protein Ouabain results in increased expression of CDH1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDH2 mRNA; Ouabain results in decreased expression of CDH2 protein |
CTD |
PMID:28795476 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDK2 mRNA; Ouabain results in decreased expression of CDK2 protein |
CTD |
PMID:20460749 PMID:21215801 PMID:31436044 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDK6 protein |
CTD |
PMID:31436044 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of CDKN1A mRNA; Ouabain results in decreased expression of CDKN1A protein Ouabain results in increased expression of CDKN1A mRNA; Ouabain results in increased expression of CDKN1A protein |
CTD |
PMID:20460749 PMID:21215801 PMID:28795476 PMID:31436044 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ckb |
creatine kinase B |
decreases activity |
EXP |
Ouabain results in decreased activity of CKB protein |
CTD |
PMID:19911114 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CLDN1 protein |
CTD |
PMID:18247327 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
affects expression |
ISO |
Ouabain affects the expression of CNPY2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
EXP |
MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] |
CTD |
PMID:26702050 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cs |
citrate synthase |
decreases activity |
EXP |
Ouabain results in decreased activity of CS protein |
CTD |
PMID:20372980 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
ISO |
Ouabain results in decreased expression of and affects the localization of CYC1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Ouabain results in increased expression of DDIT3 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of DDOST mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
increases expression |
ISO |
Ouabain results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions decreases expression |
ISO EXP |
Ouabain results in decreased expression of and results in increased phosphorylation of DRD1 protein Ouabain results in increased phosphorylation of and results in decreased expression of DRD1 protein Ouabain results in decreased expression of DRD1 mRNA |
CTD |
PMID:19626329 PMID:20132239 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Dsg1 |
desmoglein 1 |
affects expression |
ISO |
Ouabain affects the expression of DSG1 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
|
|
G |
Dut |
deoxyuridine triphosphatase |
affects expression |
ISO |
Ouabain affects the expression of DUT protein |
CTD |
PMID:17268060 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
increases expression |
ISO |
Ouabain results in increased expression of ECE1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
affects expression |
ISO |
Ouabain affects the expression of ECHS1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Edn1 |
endothelin 1 |
increases expression decreases expression |
EXP ISO |
Ouabain results in increased expression of EDN1 mRNA Ouabain results in decreased expression of EDN1 mRNA |
CTD |
PMID:15477225 PMID:28795476 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
increases expression |
EXP |
Ouabain results in increased expression of EDNRA mRNA; Ouabain results in increased expression of EDNRA protein |
CTD |
PMID:15477225 PMID:16982439 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases phosphorylation |
ISO |
Ouabain results in decreased phosphorylation of EGFR protein |
CTD |
PMID:28795476 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases expression |
ISO |
Ouabain results in increased expression of EIF2A protein |
CTD |
PMID:31436044 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:31436044 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
affects expression |
ISO |
Ouabain affects the expression of EIF3K protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:84,260,127...84,270,051
Ensembl chr 1:84,259,673...84,270,302
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Ouabain results in increased expression of ENDOG protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of ERCC4 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
decreases expression |
ISO |
Ouabain results in decreased expression of ETS1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Fadd |
Fas associated via death domain |
increases expression |
ISO |
Ouabain results in increased expression of FADD protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fancd2 |
FA complementation group D2 |
multiple interactions decreases expression |
ISO |
Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]] Ouabain results in decreased expression of FANCD2 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancf |
FA complementation group F |
decreases expression |
ISO |
Ouabain results in decreased expression of FANCF mRNA |
CTD |
PMID:24124520 |
|
NCBI chr 1:101,449,120...101,451,936
Ensembl chr 1:101,450,389...101,451,923
|
|
G |
Fanci |
FA complementation group I |
decreases expression multiple interactions |
ISO |
Ouabain results in decreased expression of FANCI mRNA Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] |
CTD |
PMID:24124520 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
increases expression |
ISO |
Ouabain results in increased expression of FARS2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr17:28,319,215...28,746,217
Ensembl chr17:28,319,280...28,746,337
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Ouabain results in increased expression of FAS protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
Ouabain results in increased expression of FASLG protein |
CTD |
PMID:31436044 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] |
CTD |
PMID:21139329 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fh |
fumarate hydratase |
affects expression |
ISO |
Ouabain affects the expression of FH protein |
CTD |
PMID:17268060 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fkbp7 |
FKBP prolyl isomerase 7 |
increases expression |
ISO |
Ouabain results in increased expression of FKBP7 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 3:61,609,384...61,623,710
Ensembl chr 3:61,608,557...61,623,280
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of FN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gc |
GC, vitamin D binding protein |
affects expression |
ISO |
Ouabain affects the expression of GC protein |
CTD |
PMID:17268060 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Glrb |
glycine receptor, beta |
increases expression |
ISO |
Ouabain results in increased expression of GLRB mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 2:166,134,616...166,207,498
Ensembl chr 2:166,134,626...166,207,489
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of GRB2 protein |
CTD |
PMID:28795476 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Gtpbp6 |
GTP binding protein 6 (putative) |
increases expression |
ISO |
Ouabain results in increased expression of GTPBP6 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
Ouabain results in increased phosphorylation of H2AX protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression |
ISO |
Ouabain results in increased expression of HEY1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
Ouabain inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions affects localization increases activity |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain affects the localization of HIF1A protein]; 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; Ouabain results in increased phosphorylation of and results in increased expression of HIF1A protein Ouabain results in increased activity of HIF1A protein |
CTD |
PMID:19647009 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
affects expression |
ISO |
Ouabain affects the expression of HNRNPA2B1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
decreases expression |
ISO |
Ouabain results in decreased expression of HNRNPDL mRNA |
CTD |
PMID:16412265 |
|
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
affects expression |
ISO |
Ouabain affects the expression of HPCAL1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hrg |
histidine-rich glycoprotein |
affects expression |
ISO |
Ouabain affects the expression of HRG protein |
CTD |
PMID:17268060 |
|
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Ouabain results in increased expression of HSPA5 protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
affects expression multiple interactions |
ISO |
Ouabain affects the expression of HSPD1 protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein]; Ouabain results in decreased expression of and affects the localization of HSPD1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
Ouabain results in increased expression of ID2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
Ouabain results in decreased expression of IL2RA mRNA |
CTD |
PMID:7593202 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
decreases expression |
ISO |
Ouabain results in decreased expression of IL2RB |
CTD |
PMID:7593202 |
|
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il6 |
interleukin 6 |
increases secretion increases expression |
ISO |
Ouabain results in increased secretion of IL6 protein Ouabain results in increased expression of IL6 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
ISO |
Ouabain results in increased expression of IL6R mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Ilk |
integrin-linked kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of ILK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Itgav |
integrin subunit alpha V |
decreases expression |
ISO |
Ouabain results in decreased expression of ITGAV mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression decreases phosphorylation |
ISO |
Ouabain results in decreased expression of JUN mRNA Ouabain results in decreased phosphorylation of JUN protein |
CTD |
PMID:28795476 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
increases expression |
ISO EXP |
Ouabain results in increased expression of KCND2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases expression decreases activity multiple interactions |
ISO |
Ouabain results in decreased expression of KCNH2 protein modified form Ouabain results in decreased activity of KCNH2 protein Ouabain inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:19139152 PMID:21158687 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of LEF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lgals1 |
galectin 1 |
affects expression increases expression |
ISO |
Ouabain affects the expression of LGALS1 protein Ouabain results in increased expression of LGALS1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Limk1 |
LIM domain kinase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of LIMK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Lss |
lanosterol synthase |
increases abundance |
ISO |
LSS protein results in increased abundance of Ouabain |
CTD |
PMID:21106941 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
increases expression |
ISO |
Ouabain results in increased expression of MAP2K6 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK1 protein] Ouabain results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK3 protein] Ouabain results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [palytoxin results in increased phosphorylation of and results in increased activity of MAPK7 protein] |
CTD |
PMID:19716839 |
|
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
affects expression |
ISO |
Ouabain affects the expression of MDH2 protein |
CTD |
PMID:17268060 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
Ouabain results in decreased expression of and results in decreased phosphorylation of MDM2 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
Ouabain results in decreased expression of MGMT protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir29b1 |
microRNA 29b-1 |
multiple interactions decreases expression |
EXP |
MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] Ouabain results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:26702050 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
decreases expression |
ISO |
Ouabain results in decreased expression of MMP13 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions |
ISO |
Ouabain results in decreased expression of MMP2 mRNA Ouabain results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:28795476 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
Ouabain results in decreased expression of MMP9 mRNA; Ouabain results in decreased expression of MMP9 protein |
CTD |
PMID:28795476 PMID:33760381 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mras |
muscle RAS oncogene homolog |
decreases expression |
ISO |
Ouabain results in decreased expression of MRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
|
|
G |
Mrtfa |
myocardin related transcription factor A |
decreases expression |
ISO |
Ouabain results in decreased expression of MRTFA mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 7:112,544,305...112,714,418
Ensembl chr 7:112,544,312...112,714,418
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of MYC mRNA; Ouabain results in decreased expression of MYC protein Ouabain results in increased expression of MYC protein |
CTD |
PMID:9653513 PMID:21215801 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl12a |
myosin light chain 12A |
increases expression |
ISO |
Ouabain results in increased expression of MYL12A protein |
CTD |
PMID:17268060 |
|
NCBI chr 9:110,891,970...110,899,655
Ensembl chr 9:110,873,959...110,916,580
|
|
G |
Mylk |
myosin light chain kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of MYLK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nectin3 |
nectin cell adhesion molecule 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of NECTIN3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:54,362,712...54,469,351
Ensembl chr11:54,364,487...54,462,519
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
increases expression |
ISO |
Ouabain results in increased expression of NECTIN4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
ISO |
Ouabain results in decreased expression of NEFL mRNA |
CTD |
PMID:28795476 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nos1 |
nitric oxide synthase 1 |
affects expression increases expression |
EXP |
Ouabain affects the expression of NOS1 protein Ouabain results in increased expression of NOS1 protein |
CTD |
PMID:12384489 PMID:15097235 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions affects expression increases expression |
EXP |
5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] Ouabain affects the expression of NOS3 protein |
CTD |
PMID:12384489 PMID:15477225 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of NPC2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
|
|
G |
Nppa |
natriuretic peptide A |
increases expression multiple interactions |
EXP |
Ouabain results in increased expression of NPPA mRNA N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of NPPA mRNA]; Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:17266992 PMID:19687166 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
decreases expression |
ISO |
Ouabain results in decreased expression of NRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Park7 |
Parkinsonism associated deglycase |
affects response to substance |
ISO |
PARK7 affects the susceptibility to Ouabain |
CTD |
PMID:16624565 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
Mitomycin promotes the reaction [Ouabain results in increased cleavage of PARP1 protein]; Ouabain promotes the reaction [Mitomycin results in increased cleavage of PARP1 protein] |
CTD |
PMID:24124520 PMID:31436044 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Ouabain results in decreased expression of PCNA mRNA; Ouabain results in decreased expression of PCNA protein |
CTD |
PMID:20460749 PMID:21215801 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd6 |
programmed cell death 6 |
increases expression |
ISO |
Ouabain results in increased expression of PDCD6 protein |
CTD |
PMID:18247327 |
|
NCBI chr 1:28,966,518...28,982,188
Ensembl chr 1:28,966,518...28,982,189
|
|
G |
Pfdn5 |
prefoldin subunit 5 |
affects expression |
ISO |
Ouabain affects the expression of PFDN5 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
|
|
G |
Pfn1 |
profilin 1 |
affects expression decreases expression |
ISO |
Ouabain affects the expression of PFN1 protein Ouabain results in decreased expression of PFN1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
decreases expression |
ISO |
Ouabain results in decreased expression of PLAUR mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of PLCG1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Ppt2 |
palmitoyl-protein thioesterase 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of PPT2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr20:4,112,520...4,132,774
Ensembl chr20:4,122,463...4,132,774
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of PRKDC protein |
CTD |
PMID:31436044 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
affects expression |
ISO |
Ouabain affects the expression of PSMB6 protein |
CTD |
PMID:17268060 |
|
NCBI chr10:55,239,256...55,241,586
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
[Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide |
CTD |
PMID:18976649 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of PTPN2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
|
|
G |
Rab11b |
RAB11B, member RAS oncogene family |
increases expression |
ISO |
Ouabain results in increased expression of RAB11B protein |
CTD |
PMID:18247327 |
|
NCBI chr 7:14,521,448...14,534,589
Ensembl chr 7:14,521,368...14,534,593
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of RAF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of RASGRF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of RGS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rhoh |
ras homolog family member H |
increases expression |
ISO |
Ouabain results in increased expression of RHOH mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
increases cleavage multiple interactions |
ISO |
Ouabain results in increased cleavage of ROCK1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK1 protein] |
CTD |
PMID:20661774 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
multiple interactions increases cleavage |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK2 protein] |
CTD |
PMID:20661774 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Rpa3 |
replication protein A3 |
affects expression |
ISO |
Ouabain affects the expression of RPA3 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
|
|
G |
Rpgrip1l |
Rpgrip1-like |
decreases expression |
ISO |
Ouabain results in decreased expression of RPGRIP1L mRNA |
CTD |
PMID:16412265 |
|
NCBI chr19:15,692,189...15,785,083
Ensembl chr19:15,692,150...15,785,083
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
affects expression |
EXP |
Ouabain affects the expression of RPS6KB1 mRNA |
CTD |
PMID:28099878 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Ryr2 |
ryanodine receptor 2 |
multiple interactions increases response to substance |
ISO |
K201 compound inhibits the reaction [RYR2 mutant form results in increased susceptibility to Ouabain] |
CTD |
PMID:20080988 |
|
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
affects expression |
ISO |
Ouabain affects the expression of S100A13 protein |
CTD |
PMID:17268060 |
|
NCBI chr 2:175,999,439...176,005,933
|
|
G |
S100b |
S100 calcium binding protein B |
increases expression |
EXP |
Ouabain results in increased expression of S100B protein |
CTD |
PMID:15581912 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions decreases expression |
ISO |
Ouabain inhibits the reaction [SGK1 protein results in increased transport of Potassium] Ouabain results in decreased expression of SGK1 mRNA |
CTD |
PMID:12590200 PMID:28795476 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sgk3 |
serum/glucocorticoid regulated kinase family, member 3 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SGK3 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr 5:9,345,761...9,472,243
Ensembl chr 5:9,346,040...9,415,476
|
|
G |
Shc3 |
SHC adaptor protein 3 |
increases expression |
ISO |
Ouabain results in increased expression of SHC3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr17:13,652,247...13,772,710
Ensembl chr17:13,651,202...13,772,710
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] |
CTD |
PMID:15804185 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Ouabain promotes the reaction [SLC22A12 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:15284287 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12541134 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
affects response to substance increases expression multiple interactions |
ISO EXP |
SLC8A1 affects the susceptibility to Ouabain Ouabain results in increased expression of SLC8A1 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein] |
CTD |
PMID:16166162 PMID:19897708 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
multiple interactions increases expression |
EXP |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of SLC9A1 mRNA] |
CTD |
PMID:19687166 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Smad4 |
SMAD family member 4 |
decreases expression |
ISO |
Ouabain results in decreased expression of SMAD4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SNAI1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SOS1 protein |
CTD |
PMID:28795476 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of SOS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:88,042,966...88,156,140
Ensembl chr 6:88,042,966...88,156,692
|
|
G |
Sphk1 |
sphingosine kinase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SPHK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
increases expression |
ISO |
Ouabain results in increased expression of TGFBR3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
|
|
G |
Tln1 |
talin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of TLN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 5:57,787,670...57,817,900
Ensembl chr 5:57,787,943...57,817,900
|
|
G |
Tln2 |
talin 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of TLN2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
increases expression |
ISO |
Ouabain results in increased expression of TNFRSF10A protein |
CTD |
PMID:31436044 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
Ouabain results in decreased expression of and results in increased phosphorylation of TP53 protein |
CTD |
PMID:31436044 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
affects expression |
ISO |
Ouabain affects the expression of TPI1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects expression |
ISO |
Ouabain affects the expression of TPT1 protein |
CTD |
PMID:17268060 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Trim63 |
tripartite motif containing 63 |
multiple interactions |
ISO |
[Ouabain co-treated with Botulinum Toxins, Type A] affects the expression of TRIM63 mRNA |
CTD |
PMID:21139329 |
|
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
increases expression |
EXP |
Ouabain results in increased expression of TRPC1 protein |
CTD |
PMID:19897708 |
|
NCBI chr 8:96,263,322...96,314,220
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
increases expression multiple interactions |
EXP |
Ouabain results in increased expression of TRPC6 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein] |
CTD |
PMID:19897708 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
increases expression |
ISO |
Ouabain results in increased expression of TWIST1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Txn1 |
thioredoxin 1 |
affects expression |
ISO |
Ouabain affects the expression of TXN protein |
CTD |
PMID:17268060 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Vim |
vimentin |
decreases expression |
ISO |
Ouabain results in decreased expression of VIM mRNA |
CTD |
PMID:33760381 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of ZFHX3 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
|
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
EXP |
ponasterone A results in decreased activity of CASP3 protein L-161982 inhibits the reaction [ponasterone A results in decreased activity of CASP3 protein] |
CTD |
PMID:16396944 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
EXP |
[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of DNM1L protein |
CTD |
PMID:20164189 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
affects expression |
ISO |
ponasterone A affects the expression of FHIT protein |
CTD |
PMID:17019711 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fis1 |
fission, mitochondrial 1 |
multiple interactions |
EXP |
[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein] |
CTD |
PMID:20164189 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Mfn2 |
mitofusin 2 |
increases expression |
EXP |
[ponasterone A results in increased expression of PINK1 protein] which results in increased expression of MFN2 protein |
CTD |
PMID:20164189 |
|
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions increases expression |
EXP |
[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of DNM1L protein; [ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein] [ponasterone A results in increased expression of PINK1 protein] which results in increased expression of MFN2 protein; ponasterone A results in increased expression of PINK1 protein |
CTD |
PMID:20164189 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
L-161982 inhibits the reaction [ponasterone A results in increased expression of PTGS2 protein] |
CTD |
PMID:16396944 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
increases expression |
ISO |
ponasterone A results in increased expression of UGT1A3 protein |
CTD |
PMID:17058234 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases transport |
ISO |
ABCB1 protein results in increased transport of Strophanthidin |
CTD |
PMID:26708294 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
increases expression multiple interactions |
ISO |
Strophanthidin results in increased expression of G6PC1 mRNA Strophanthidin promotes the reaction [RORC protein binds to G6PC1 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
Strophanthidin results in increased expression of and results in increased secretion of IL17A protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17f |
interleukin 17F |
multiple interactions |
ISO |
Strophanthidin results in increased expression of and results in increased secretion of IL17F protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression multiple interactions |
ISO |
Strophanthidin results in increased expression of NPAS2 mRNA Strophanthidin promotes the reaction [RORC protein binds to NPAS2 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions increases expression |
ISO |
RORC protein promotes the reaction [Strophanthidin results in increased expression of RORC mRNA]; Strophanthidin promotes the reaction [RORC protein binds to G6PC1 promoter]; Strophanthidin promotes the reaction [RORC protein binds to NPAS2 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|